Publication Ethics Policy

The paramount objective of the KYAMC Journal is to foster best practices within the medical research community and uphold absolute integrity throughout the publishing process.

We diligently adhere to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE), as well as the Code of Conduct and Best Practice Guidelines for Journal Editors established by the Committee on Publication Ethics (COPE).

  1. Research Ethics and Participant Protection
  • Research Approvals (IRB/ERC): All human and animal research published in the journal must have received formal prior approval from a recognized Institutional Review Board (IRB) or Ethical Review Committee (ERC).
  • Informed Consent: Authors must secure and verify informed consent from all human participants involved in the study. Patient anonymity must be strictly protected.
  • Human and Animal Rights: * Human Subjects: Submissions must include an explicit statement demonstrating compliance with institutional and national ethical standards (aligned with the Declaration of Helsinki).
    • Animal Subjects: Authors must indicate compliance with institutional and/or national guidelines for the care and use of laboratory animals.
  • Clinical Trial Registration: All clinical trials must be registered in a public trials registry (e.g., ClinicalTrials.gov or WHO International Clinical Trials Registry Platform) adhering to local and international registration standards.
  1. Authorship and Manuscript Originality
  • Authorship and Contributorship: All listed authors and co-authors must satisfy the strict ICMJE criteria for authorship. Appropriate credit must be attributed to each contributor, and authors are required to explicitly state their individual roles within the manuscript.
  • Originality and Plagiarism: Authors must guarantee that the submitted manuscript represents their own original work. It must not be under consideration, or previously published, elsewhere. Any incorporation of outside ideas, text, or data must be properly quoted and cited.
  • Reporting Standards: Authors of original research must provide an accurate account of their work alongside an objective discussion of its medical significance. Authors of clinical trials, interventional studies, and systematic reviews are required to follow the relevant EQUATOR Network checklists (e.g., CONSORT, STROBE, PRISMA).
  1. Data Integrity and Transparency
  • Data Access and Citation: To maintain transparency, authors may be requested to provide the raw, anonymized datasets related to their paper for editorial review. Authors must be willing to make this data accessible if required. Data must be cited in the reference list using standard scholarly formats.
  • Acknowledgment of Sources: Proper, explicit acknowledgment must be given to any third-party contributions, including funding bodies, technical assistants, or medical writers.
  • Declaration of Conflicts of Interest: All submissions must include a comprehensive disclosure of any financial, personal, or institutional relationships that could potentially bias or be perceived to bias the work.

⚠️ Authors' Ethical Responsibility Statement

Authors retain ultimate accountability for all aspects of their work. This includes securing data access, verifying data integrity, and confirming the accuracy of all statistical analyses. Any subsequent concerns regarding the precision or integrity of a published article must be transparently investigated and corrected by the authors in communication with the Editorial Office.